Towards Healthcare

Hygienic and Aseptic Valves for Pharmaceuticals and Biotechnology Companies and Expansion Strategies

Date : 26 March 2026

Top Companies in the Hygienic and Aseptic Valves for Pharmaceuticals and Biotechnology Market

Hygienic and Aseptic Valves for Pharmaceuticals and Biotechnology Market Companies are Emerson Electric Co., Crane Co., ITT Inc., GEA Group AG, Alfa Laval AB, Bürkert Fluid Control Systems

Now it’s effortless to manage all your Market data in one powerful place - Access the Dashboard

Company Profile

Companies Headquarters Offerings
Emerson Electric Co St. Louis, USA  Provides sterile diaphragm and control valves with automation support for precise fluid handling in bioprocessing
Crane Co. Stamford, USA Offers hygienic diaphragm and lined valves designed for safe and contamination-free pharmaceutical operations
ITT Inc. White Plains, USA Develops sanitary valve solutions focused on reliable fluid control in critical pharma and biotech processes.
GEA Group AG Düsseldorf, Germany Supplies aseptic valve systems, including mixproof and single-seat valves for high-purity production lines
Alfa Laval AB Lund, Sweden Delivers hygienic valves such as butterfly and tank valves suited for clean and sterile applications
Bürkert Fluid Control Systems Ingelfingen, Germany Provides compact, hygienic valves and automated flow control solutions for sterile environments.
SPX FLOW, Inc. Charlotte, USA Offers a wide range of aseptic and hygienic valves, including mixproof systems for biopharma manufacturing

Market Growth

The global hygienic and aseptic valves for pharmaceuticals and biotechnology market size was estimated at USD 1.24 billion in 2025 and is predicted to increase from USD 1.33 billion in 2026 to approximately USD 2.57 billion by 2035, expanding at a CAGR of 7.54% from 2026 to 2035.

Hygienic and Aseptic Valves for Pharmaceuticals and Biotechnology Market Size is USD 1.33 Billion in 2026.

What are the Recent Developments in the Market?

  • In January 2026, the industry players introduced energy-efficient valve systems designed to reduce water and energy usage, supporting sustainability goals in pharmaceutical manufacturing.
  • In October 2024, the new-generation mixproof valves were developed to allow simultaneous processing of multiple fluids, enhancing efficiency while minimizing cross-contamination risks.